Dr. Michelle Kip has received her PhD (cum laude) from the University of Twente, Enschede, the Netherlands, in April 2018. Her thesis was entitled: "Early Health Technology Assessment of Point-of-Care and Laboratory Diagnostics". Currently, she works as a postdoctoral researcher at the Health Technology & Services Research Department at the University of Twente. She is experienced in the field of (early) Health Technology Assessment, and her research focuses on methods to evaluate the health economic impact of medical technologies in several phases of development, using cost-effectiveness analysis and simulation modeling. Besides evaluating the health economic impact of medical technologies, she is also experienced in the field of Multi-Criteria Decision Analysis, which includes methods to evaluate stakeholders’ preferences with regard to (new) medical technologies, as well as in expert elicitation.

During her postdoc, Michelle will work on the UCAN CAN-DU project, which aims to develop a biomarker based predictive testing approach to optimize clinical management in juvenile idiopathic arthritis compared to current standard of practice. Within this project, she will be involved in quantifying the impact of (personalized treatment strategies for) juvenile idiopathic arthritis in terms of costs and health outcomes.


  • Medicine and Dentistry

    • Patient
    • Health Care Cost
    • Diagnosis
    • Laboratory
    • Child
    • Cost-Effectiveness Analysis
    • General Practitioner
  • Nursing and Health Professions

    • Juvenile Rheumatoid Arthritis



Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysisBMC Primary Care, 24(1), Article 42. Heerink, J. S., Nies, J., Koffijberg, H., Oudega, R., Kip, M. M. A. & Kusters, R.https://doi.org/10.1186/s12875-023-01992-zWithdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?Pediatric rheumatology online journal, 21(1), Article 69, 69. van Til, J. A., Kip, M. M. A., Schatorjé, E. J. H., Currie, G., Twilt, M., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N., Yeung, R. S. M., Groothuis-Oudshoorn, C. G. M. K., Warta, S., Marshall, D. A. & IJzerman, M. J.https://doi.org/10.1186/s12969-023-00845-4What matters most to pediatric rheumatologists in deciding whether to discontinue biologics in a child with juvenile idiopathic arthritis? A best-worst scaling surveyClinical rheumatology, 42(8), 2173-2180. Currie, G. R., Groothuis-Oudshoorn, C. G. M., Twilt, M., Kip, M. M. A., IJzerman, M. J., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. & Marshall, D. A.https://doi.org/10.1007/s10067-023-06616-6Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: A real-world data analysisRheumatology, 62(SI2), SI170-SI180. Kip, M. M. A., de Roock, S., Currie, G., Marshall, D. A., Grazziotin, L. R., Twilt, M., Yeung, R. S. M., Benseler, S. M., Vastert, S. J., Wulffraat, N., Swart, J. F. & IJzerman, M. J.https://doi.org/10.1093/rheumatology/keac299
As open as possible, as closed as necessary: how to find the right balance in sharing citizen science data for health?Proceedings of Science, 418, Article 028. Wolkorte, R., Heesink, L. & Kip, M. M. A.https://pos.sissa.it/418/028/pdfFactors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritisPediatric Rheumatology, 20(1), Article 51, 1-12. Grazziotin, L. R., Currie, G., Twilt, M., IJzerman, M. J., Kip, M. M. A., Koffijberg, H., Bonsel, G., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. S. M., Armbrust, W., van den Berg, J. M. & Marshall, D. A.https://doi.org/10.1186/s12969-022-00713-7The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impactBMC health services research, 22(1), Article 1529. Lingervelder, D., Kip, M. M. A., Wiese, E. D., Koffijberg, H., Ijzerman, M. J. & Kusters, R.https://doi.org/10.1186/s12913-022-08782-wCosts of Hospital-Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care SystemArthritis Care and Research, 74(10), 1585-1592. Kip, M. M. A., de Roock, S., van den Berg, I., Currie, G., Marshall, D. A., Grazziotin, L. R., Twilt, M., Yeung, R. S. M., Benseler, S. M., Vastert, S. J., Wulffraat, N., Swart, J. F. & IJzerman, M. J.https://doi.org/10.1002/acr.24621Perspectives of Pediatric Rheumatologists on Initiating and Tapering Biologics in Patients with Juvenile Idiopathic Arthritis: A Formative Qualitative StudyThe Patient, 15(5), 599-609. Currie, G. R., Pham, T., Twilt, M., IJzerman, M. J., Hull, P. M., Kip, M. M. A., Benseler, S. M., Hazlewood, G. S., Yeung, R. S. M., Wulffraat, N. M., Swart, J. F., Vastert, S. J. & Marshall, D. A.https://doi.org/10.1007/s40271-022-00575-xReal-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational studyPediatric Rheumatology, 20(1), Article 25. Grazziotin, L. R., Currie, G., Twilt, M., Ijzerman, M. J., Kip, M. M. A., Koffijberg, H., Benseler, S. M., Swart, J. F., Vastert, S. J., Wulffraat, N. M., Yeung, R. S. M. & Marshall, D. A.https://doi.org/10.1186/s12969-022-00682-x


Vakken collegejaar 2023/2024

Vakken in het huidig collegejaar worden toegevoegd op het moment dat zij definitief zijn in het Osiris systeem. Daarom kan het zijn dat de lijst nog niet compleet is voor het gehele collegejaar.

Vakken collegejaar 2022/2023


Universiteit Twente

Technohal (gebouwnr. 18), kamer 3101
Hallenweg 5
7522 NH Enschede

Navigeer naar locatie


Scan de QR-code of
Download vCard